Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Strategic Collaboration Between WuXi XDC and Earendil Labs to Enhance ADC Development

Strategic Collaboration Between WuXi XDC and Earendil Labs to Enhance ADC Development

SHANGHAI, 27 February 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO) that excels in antibody-drug conjugates…

Read more about the article Key Players in Pharma, Biotech, and Health Sector Featured on the 2026 Changemakers List

Key Players in Pharma, Biotech, and Health Sector Featured on the 2026 Changemakers List

In an important announcement, CNBC's Julia Boorstin has revealed the names of significant contributors to the pharmaceutical, biotechnology, and health sectors included in the 2026 Changemakers list. This list acknowledges…

Read more about the article Asahi Kasei Acquires Aicuris for €780 Million to Strengthen Antiviral Portfolio

Asahi Kasei Acquires Aicuris for €780 Million to Strengthen Antiviral Portfolio

Asahi Kasei, the Japanese pharmaceutical company, has entered into an agreement to acquire the German biotechnology firm Aicuris. This strategic move is aimed at enhancing Asahi Kasei's capabilities in antiviral…

  • Go to the previous page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept